跳至主要内容
临床试验/JPRN-jRCT1030230130
JPRN-jRCT1030230130招募中Unknown

Prospective observational study to evaluate the efficacy of fosnetupitant for long delayed chemotherapy-induced nausea and vomiting in patients recieving platinam-based chemotherapy (LODEC-N) - Long delayed emesis induced by cancer chemotherapy can be suppressed by NK1 receptor antagonist (LODEC-N)

Seiichiro Kuroda0 个研究点目标入组 100 人开始时间: 2023年6月12日最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • (i) written informed consent to participate in this study
  • (ii) patients undergoing chemotherapy and administered standard antiemetic therapy
  • (iii) age >18 years
  • (iv) male or female
  • (v) Eastern Cooperative Oncology Group performance status (ECOG PS) of 0-1

排除标准

  • (i) administration of low or minimal emetic risk rejimen
  • (ii) the use of opioids
  • (iii) patients with a history of habitual vomiting
  • (iv) brain metastasis having uncontrollable symptoms
  • (v) current radio therapy (within three months)
  • (vi) administration of chemotherapy within three months before enrolment
  • (vii) experienced nausea and vomiting within one week before enrollment
  • (viii) the current use of antiemetic agents within two week before enrollment
  • (ix) pregnant and lactating women

研究者

发起方
Seiichiro Kuroda

相似试验

ong delayed emesis induced by cancer chemotherapy... | 临床试验